BioScience Laboratories, Inc. and Synomics Pharmaceutical Services announced today their formal partnership to provide a fully integrated phase 1 clinical study capability for trials in healthy human subjects.

Drug companies increasingly find it difficult to recruit enough eligible lupus patients to participate in their clinical trials. The LFA will conduct a live web chat to provide patients the information they need to make an informed decision.

Dr. Wong boasts 24 years of expertise in the fields of oncology, HIV drug development and project management.

Company aims to develop novel therapies to prevent blindness

Company aims to develop pharmaceutical therapeutics for blinding eye diseases, including Age-Related Macular Degeneration and Diabetic Retinopathy